CD40 Agonist Restores the Antitumor Efficacy of Anti-PD1 Therapy in Muscle-Invasive Bladder Cancer in an IFN I/II-Mediated Manner
- Resource Type
- Journal
- Source
CANCER IMMUNOLOGY RESEARCH ; SEP 2020, 8 9, p1180-p1192, 13p.- Subject
- Language
- English
- ISSN
- 23266074